FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Somatic Gene Mutation Detection System
PMA: P120022
·
Supplement: S012
·
Decision Nov 9, 2015
Classifications
1
FEI Numbers
11
Registration Numbers
11
Basic Information
- Device Name
- Somatic Gene Mutation Detection System
- Trade Name
- THERASCREEN EGFR RGQ PCR KIT
- PMA Number
- P120022
- Supplement Number
- S012
- Device Class
- FDA Class 3
- Product Code
- OWD
- Generic Name
- Somatic gene mutation detection system
- Medical Specialty
- Unknown
- Advisory Committee
- Pathology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- November 9, 2015
- Date Received
- September 28, 2015
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
APPROVAL FOR A MANUFACTURING SITE LOCATED AT QIAGEN GMBH IN HILDEN, GERMANY.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OWD | Somatic Gene Mutation Detection System | FDA class 3 | Unknown |